Advertisement

Index by author

March 01, 1990; Volume 37,Issue 3

A

  1. Ayer, D E

    1. Studies on the mechanism of interactions between anesthetic steroids and gamma-aminobutyric acidA receptors.
      W B Im, D P Blakeman, J P Davis and D E Ayer
      Molecular Pharmacology March 1990, 37 (3) 429-434;

B

  1. Báez, A

    1. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
      A Báez, J F Riou, J B Le Pecq and G Riou
      Molecular Pharmacology March 1990, 37 (3) 377-382;

  2. Balzarini, J

    1. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
      J Balzarini, E De Clercq, H Baumgartner, M Bodenteich and H Griengl
      Molecular Pharmacology March 1990, 37 (3) 395-401;
    2. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
      J Balzarini, R Bernaerts, A Verbruggen and E De Clercq
      Molecular Pharmacology March 1990, 37 (3) 402-407;

  3. Bast, A

    1. Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen.
      G R Haenen, B M De Rooij, N P Vermeulen and A Bast
      Molecular Pharmacology March 1990, 37 (3) 412-422;

  4. Baumgartner, H

    1. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
      J Balzarini, E De Clercq, H Baumgartner, M Bodenteich and H Griengl
      Molecular Pharmacology March 1990, 37 (3) 395-401;

  5. Bernaerts, R

    1. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
      J Balzarini, R Bernaerts, A Verbruggen and E De Clercq
      Molecular Pharmacology March 1990, 37 (3) 402-407;

  6. Blakeman, D P

    1. Studies on the mechanism of interactions between anesthetic steroids and gamma-aminobutyric acidA receptors.
      W B Im, D P Blakeman, J P Davis and D E Ayer
      Molecular Pharmacology March 1990, 37 (3) 429-434;

  7. Bockaert, J

    1. Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives.
      J Bockaert, M Sebben and A Dumuis
      Molecular Pharmacology March 1990, 37 (3) 408-411;

  8. Bodenteich, M

    1. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
      J Balzarini, E De Clercq, H Baumgartner, M Bodenteich and H Griengl
      Molecular Pharmacology March 1990, 37 (3) 395-401;

  9. Bös, M

    1. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
      A M Cesura, M Bös, M D Galva, R Imhof and M Da Prada
      Molecular Pharmacology March 1990, 37 (3) 358-366;

  10. Buller, A L

    1. Functional acetylcholine receptors expressed in Xenopus oocytes after injection of Torpedo beta, gamma, and delta subunit RNAs are a consequence of endogenous oocyte gene expression.
      A L Buller and M M White
      Molecular Pharmacology March 1990, 37 (3) 423-428;

C

  1. Cesura, A M

    1. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
      A M Cesura, M Bös, M D Galva, R Imhof and M Da Prada
      Molecular Pharmacology March 1990, 37 (3) 358-366;

  2. Chang, R S

    1. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
      R S Chang and V J Lotti
      Molecular Pharmacology March 1990, 37 (3) 347-351;

  3. Connor, H D

    1. Reaction of glutathione with a free radical metabolite of carbon tetrachloride.
      H D Connor, L B Lacagnin, K T Knecht, R G Thurman and R P Mason
      Molecular Pharmacology March 1990, 37 (3) 443-451;

  4. Costa, T

    1. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.
      T Costa, J Lang, C Gless and A Herz
      Molecular Pharmacology March 1990, 37 (3) 383-394;

D

  1. Da Prada, M

    1. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
      A M Cesura, M Bös, M D Galva, R Imhof and M Da Prada
      Molecular Pharmacology March 1990, 37 (3) 358-366;

  2. Dave, J R

    1. Ethanol withdrawal seizures produce increased c-fos mRNA in mouse brain.
      J R Dave, B Tabakoff and P L Hoffman
      Molecular Pharmacology March 1990, 37 (3) 367-371;

  3. Davis, J P

    1. Studies on the mechanism of interactions between anesthetic steroids and gamma-aminobutyric acidA receptors.
      W B Im, D P Blakeman, J P Davis and D E Ayer
      Molecular Pharmacology March 1990, 37 (3) 429-434;

  4. De Clercq, E

    1. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
      J Balzarini, E De Clercq, H Baumgartner, M Bodenteich and H Griengl
      Molecular Pharmacology March 1990, 37 (3) 395-401;
    2. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
      J Balzarini, R Bernaerts, A Verbruggen and E De Clercq
      Molecular Pharmacology March 1990, 37 (3) 402-407;

  5. De Rooij, B M

    1. Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen.
      G R Haenen, B M De Rooij, N P Vermeulen and A Bast
      Molecular Pharmacology March 1990, 37 (3) 412-422;

  6. Donné-op Den Kelder, G M

    1. Mechanisms of activation of phenacetin to reactive metabolites by cytochrome P-450: a theoretical study involving radical intermediates.
      L Koymans, J H Van Lenthe, G M Donné-op Den Kelder and N P Vermeulen
      Molecular Pharmacology March 1990, 37 (3) 452-460;

  7. Dumuis, A

    1. Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives.
      J Bockaert, M Sebben and A Dumuis
      Molecular Pharmacology March 1990, 37 (3) 408-411;

F

  1. Farber, J L

    1. Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress.
      I Sakaida, M E Kyle and J L Farber
      Molecular Pharmacology March 1990, 37 (3) 435-442;

G

  1. Gago, F

    1. Netropsin binding to poly[d(IC)].poly[IC)] and poly[d(GC].poly[d(GC)]: a computer simulation.
      F Gago and W G Richards
      Molecular Pharmacology March 1990, 37 (3) 341-346;

  2. Galva, M D

    1. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
      A M Cesura, M Bös, M D Galva, R Imhof and M Da Prada
      Molecular Pharmacology March 1990, 37 (3) 358-366;

  3. Gless, C

    1. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.
      T Costa, J Lang, C Gless and A Herz
      Molecular Pharmacology March 1990, 37 (3) 383-394;

  4. Grapengiesser, E

    1. Sulfonylurea mimics the effect of glucose in inducing large amplitude oscillations of cytoplasmic Ca2+ in pancreatic beta-cells.
      E Grapengiesser, E Gylfe and B Hellman
      Molecular Pharmacology March 1990, 37 (3) 461-467;

  5. Griengl, H

    1. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
      J Balzarini, E De Clercq, H Baumgartner, M Bodenteich and H Griengl
      Molecular Pharmacology March 1990, 37 (3) 395-401;

  6. Guillouzo, A

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

  7. Gylfe, E

    1. Sulfonylurea mimics the effect of glucose in inducing large amplitude oscillations of cytoplasmic Ca2+ in pancreatic beta-cells.
      E Grapengiesser, E Gylfe and B Hellman
      Molecular Pharmacology March 1990, 37 (3) 461-467;

H

  1. Haenen, G R

    1. Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen.
      G R Haenen, B M De Rooij, N P Vermeulen and A Bast
      Molecular Pharmacology March 1990, 37 (3) 412-422;

  2. Hayden, P J

    1. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria.
      P J Hayden and J L Stevens
      Molecular Pharmacology March 1990, 37 (3) 468-476;

  3. Hellman, B

    1. Sulfonylurea mimics the effect of glucose in inducing large amplitude oscillations of cytoplasmic Ca2+ in pancreatic beta-cells.
      E Grapengiesser, E Gylfe and B Hellman
      Molecular Pharmacology March 1990, 37 (3) 461-467;

  4. Herz, A

    1. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.
      T Costa, J Lang, C Gless and A Herz
      Molecular Pharmacology March 1990, 37 (3) 383-394;

  5. Hoffman, P L

    1. Ethanol withdrawal seizures produce increased c-fos mRNA in mouse brain.
      J R Dave, B Tabakoff and P L Hoffman
      Molecular Pharmacology March 1990, 37 (3) 367-371;

I

  1. Im, W B

    1. Studies on the mechanism of interactions between anesthetic steroids and gamma-aminobutyric acidA receptors.
      W B Im, D P Blakeman, J P Davis and D E Ayer
      Molecular Pharmacology March 1990, 37 (3) 429-434;

  2. Imhof, R

    1. Characterization of the binding of [3H]Ro 41-1049 to the active site of human monoamine oxidase-A.
      A M Cesura, M Bös, M D Galva, R Imhof and M Da Prada
      Molecular Pharmacology March 1990, 37 (3) 358-366;

K

  1. Ketterer, B

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

  2. Knecht, K T

    1. Reaction of glutathione with a free radical metabolite of carbon tetrachloride.
      H D Connor, L B Lacagnin, K T Knecht, R G Thurman and R P Mason
      Molecular Pharmacology March 1990, 37 (3) 443-451;

  3. Koymans, L

    1. Mechanisms of activation of phenacetin to reactive metabolites by cytochrome P-450: a theoretical study involving radical intermediates.
      L Koymans, J H Van Lenthe, G M Donné-op Den Kelder and N P Vermeulen
      Molecular Pharmacology March 1990, 37 (3) 452-460;

  4. Kozikowski, A P

    1. Structural determinants of affinity for the phencyclidine binding site of the N-methyl-D-aspartate receptor complex: discovery of a rigid phencyclidine analogue of high binding affinity.
      A P Kozikowski and Y P Pang
      Molecular Pharmacology March 1990, 37 (3) 352-357;

  5. Kyle, M E

    1. Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress.
      I Sakaida, M E Kyle and J L Farber
      Molecular Pharmacology March 1990, 37 (3) 435-442;

L

  1. Lacagnin, L B

    1. Reaction of glutathione with a free radical metabolite of carbon tetrachloride.
      H D Connor, L B Lacagnin, K T Knecht, R G Thurman and R P Mason
      Molecular Pharmacology March 1990, 37 (3) 443-451;

  2. Lang, J

    1. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions.
      T Costa, J Lang, C Gless and A Herz
      Molecular Pharmacology March 1990, 37 (3) 383-394;

  3. Le Pecq, J B

    1. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
      A Báez, J F Riou, J B Le Pecq and G Riou
      Molecular Pharmacology March 1990, 37 (3) 377-382;

  4. Lotti, V J

    1. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
      R S Chang and V J Lotti
      Molecular Pharmacology March 1990, 37 (3) 347-351;

M

  1. Mason, R P

    1. Reaction of glutathione with a free radical metabolite of carbon tetrachloride.
      H D Connor, L B Lacagnin, K T Knecht, R G Thurman and R P Mason
      Molecular Pharmacology March 1990, 37 (3) 443-451;

  2. Morel, F

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

P

  1. Pang, Y P

    1. Structural determinants of affinity for the phencyclidine binding site of the N-methyl-D-aspartate receptor complex: discovery of a rigid phencyclidine analogue of high binding affinity.
      A P Kozikowski and Y P Pang
      Molecular Pharmacology March 1990, 37 (3) 352-357;

  2. Pemble, S

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

R

  1. Ratanasavanh, D

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

  2. Richards, W G

    1. Netropsin binding to poly[d(IC)].poly[IC)] and poly[d(GC].poly[d(GC)]: a computer simulation.
      F Gago and W G Richards
      Molecular Pharmacology March 1990, 37 (3) 341-346;

  3. Riou, G

    1. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
      A Báez, J F Riou, J B Le Pecq and G Riou
      Molecular Pharmacology March 1990, 37 (3) 377-382;

  4. Riou, J F

    1. Interaction of DNA intercalator 3-nitrobenzothiazolo (3,2-a)quinolinium with DNA topoisomerases: a possible-mechanism for its biological activity.
      A Báez, J F Riou, J B Le Pecq and G Riou
      Molecular Pharmacology March 1990, 37 (3) 377-382;

  5. Rogiers, V

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

S

  1. Sakaida, I

    1. Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress.
      I Sakaida, M E Kyle and J L Farber
      Molecular Pharmacology March 1990, 37 (3) 435-442;

  2. Sebben, M

    1. Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives.
      J Bockaert, M Sebben and A Dumuis
      Molecular Pharmacology March 1990, 37 (3) 408-411;

  3. Stevens, J L

    1. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria.
      P J Hayden and J L Stevens
      Molecular Pharmacology March 1990, 37 (3) 468-476;

T

  1. Tabakoff, B

    1. Ethanol withdrawal seizures produce increased c-fos mRNA in mouse brain.
      J R Dave, B Tabakoff and P L Hoffman
      Molecular Pharmacology March 1990, 37 (3) 367-371;

  2. Taylor, J B

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

  3. Thurman, R G

    1. Reaction of glutathione with a free radical metabolite of carbon tetrachloride.
      H D Connor, L B Lacagnin, K T Knecht, R G Thurman and R P Mason
      Molecular Pharmacology March 1990, 37 (3) 443-451;

V

  1. Vandenberghe, Y

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

  2. Van Lenthe, J H

    1. Mechanisms of activation of phenacetin to reactive metabolites by cytochrome P-450: a theoretical study involving radical intermediates.
      L Koymans, J H Van Lenthe, G M Donné-op Den Kelder and N P Vermeulen
      Molecular Pharmacology March 1990, 37 (3) 452-460;

  3. Verbruggen, A

    1. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
      J Balzarini, R Bernaerts, A Verbruggen and E De Clercq
      Molecular Pharmacology March 1990, 37 (3) 402-407;

  4. Vercruysse, A

    1. Changes in expression of mRNA coding for glutathione S-transferase subunits 1-2 and 7 in cultured rat hepatocytes.
      Y Vandenberghe, F Morel, S Pemble, J B Taylor, V Rogiers, D Ratanasavanh, A Vercruysse, B Ketterer and A Guillouzo
      Molecular Pharmacology March 1990, 37 (3) 372-376;

  5. Vermeulen, N P

    1. Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen.
      G R Haenen, B M De Rooij, N P Vermeulen and A Bast
      Molecular Pharmacology March 1990, 37 (3) 412-422;
    2. Mechanisms of activation of phenacetin to reactive metabolites by cytochrome P-450: a theoretical study involving radical intermediates.
      L Koymans, J H Van Lenthe, G M Donné-op Den Kelder and N P Vermeulen
      Molecular Pharmacology March 1990, 37 (3) 452-460;

W

  1. White, M M

    1. Functional acetylcholine receptors expressed in Xenopus oocytes after injection of Torpedo beta, gamma, and delta subunit RNAs are a consequence of endogenous oocyte gene expression.
      A L Buller and M M White
      Molecular Pharmacology March 1990, 37 (3) 423-428;
Back to top

In this issue

Advertisement